Gut microbiome predictors of treatment response and recurrence in primaryClostridium difficileinfection

RecurrentClostridium difficileinfection associates with distinct bile acid and microbiome profiles

(2016) J. R. Allegretti et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Developing a Clinical Prediction Rule for First Hospital-Onset Clostridium difficile Infections: A Retrospective Observational Study

(2016) Anne Press et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection

(2016) Emmanuel Montassier et al.   Genome Medicine

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection

(2015) G. Cammarota et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Economic Impact of Clostridium difficile Infection: A Systematic Review

(2015) Natasha Nanwa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clostridium difficile Infection

(2015) Daniel A. Leffler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection

(2015) Emily G. McDonald et al.   JAMA Internal Medicine

Gut Microbiota-Produced Succinate Promotes C. difficile Infection after Antibiotic Treatment or Motility Disturbance

(2014) Jessica A. Ferreyra et al.   Cell Host & Microbe

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

(2014) Stuart Johnson et al.   CLINICAL INFECTIOUS DISEASES

Clostridium difficile and the microbiota

(2014) Anna M. Seekatz et al.   JOURNAL OF CLINICAL INVESTIGATION

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

Multistate Point-Prevalence Survey of Health Care–Associated Infections

(2014) Shelley S. Magill et al.   NEW ENGLAND JOURNAL OF MEDICINE

Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non-C. difficile-Associated Diarrhea from Healthy Controls

(2014) A. M. Schubert et al.   mBio

Association betweenFaecalibacterium prausnitziiReduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature

(2014) Yuan Cao et al.   Gastroenterology Research and Practice

Meta-analyses of studies of the human microbiota

(2013) C. A. Lozupone et al.   GENOME RESEARCH

Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea

(2013) V. C. Antharam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens

(2013) Katharine M. Ng et al.   NATURE

Clostridium difficile infection: management strategies for a difficult disease

(2013) Sahil Khanna et al.   Therapeutic Advances in Gastroenterology

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

(2012) B. Guo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains

(2012) C. Rousseau et al.   CLINICAL INFECTIOUS DISEASES

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management

(2012) D. W. Eyre et al.   CLINICAL INFECTIOUS DISEASES

Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

(2012) J Gregory Caporaso et al.   ISME Journal

Clostridium difficile Infection: New Insights Into Management

(2012) Sahil Khanna et al.   MAYO CLINIC PROCEEDINGS

Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice

(2012) Trevor D. Lawley et al.   PLoS Pathogens

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

(2012) Xochitl C Morgan et al.   GENOME BIOLOGY

Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota

(2011) M. C. Rea et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Cytoscape 2.8: new features for data integration and network visualization

(2010) M. E. Smoot et al.   BIOINFORMATICS

Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of NosocomialClostridum difficile–Associated Disease

(2010) Amee R. Manges et al.   JOURNAL OF INFECTIOUS DISEASES

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection

(2009) R. TURCO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proton pump inhibitors increase significantly the risk ofClostridium difficileinfection in a low-endemicity, non-outbreak hospital setting

(2008) B. R. DALTON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection

(2008) Mary Y. Hu et al.   GASTROENTEROLOGY

Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea

(2008) Ju Young Chang et al.   JOURNAL OF INFECTIOUS DISEASES

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE